Table 4.
GLUT1 expression in EC according to clinicopathological variables.
| GLUT1 Expression | Low Expression (% Total) |
High Expression (% Total) |
p Value |
|---|---|---|---|
| Stage | |||
| I | 8 (62) | 5 (38) | 0.081 |
| II | 10 (91) | 1 (9) | |
| III | 19 (83) | 4 (17) | |
| IV | 0 (0) | 1 (100) | |
| Tumour (pT) | |||
| T1 | 8 (89) | 1 (11) | 0.406 |
| T2 | 8 (62) | 5 (38) | |
| T3 | 20 (80) | 5 (20) | |
| T4 | 1 (100) | 0 (0) | |
| Lymph node metastasis (pN) | |||
| N0 | 15 (71) | 6 (29) | 0.575 |
| N1 | 10 (91) | 1 (9) | |
| N2 | 7 (79) | 3 (30) | |
| N3 | 5 (83) | 1 (17) | |
| Distant metastasis (M) | |||
| M0 | 37 (79) | 10 (21) | 0.064 |
| M1 | 0 (0) | 1 (100) | |
| Distant recurrence (DR) | |||
| No | 27 (87) | 4 (13) | 0.026 |
| Yes | 10 (59) | 7 (41) | |
| Keratinization Degree | |||
| Non-keratinized | 23 (77) | 7 (23) | 0.727 |
| Moderately keratinized | 2 (100) | 0 (0) | |
| Keratinized | 12 (75) | 4 (25) | |
| Differentiation Degree | |||
| Well-differentiated | 3 (43) | 4 (57) | 0.081 |
| Moderately differentiated | 20 (77) | 6 (23) | |
| Poorly differentiated | 9 (90) | 1 (10) | |
| Missing information | 5 (100) | 0 (0) | |
| Extra-tumoral growth | |||
| Present | 9 (75) | 3 (25) | 0.563 |
| Absent | 28 (78) | 8 (22) | |
| Lymphatic Permeation | |||
| Present | 15 (71) | 6 (29) | 0.316 |
| Absent | 22 (81) | 5 (19) | |
| Vascular Permeation | |||
| Present | 15 (71) | 6 (29) | 0.316 |
| Absent | 22 (81) | 5 (19) | |
| Neural Permeation | |||
| Present | 10 (77) | 3 (23) | 0.632 |
| Absent | 27 (77) | 8 (23) |